COVID-19: Government's strategy of delaying second coronavirus vaccine dose further vindicated

Now we have the first robust data on the real world effectiveness of these vaccines. And it shows that both the Pfizer/BioNTech and Oxford/AstraZeneca vaccines are highly effective in reducing COVID-19 infections among older people aged 70 and over. That means a reduction in hospital admissions and that means a reduction in the number of people dying of coronavirus.